These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9234271)
1. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments. Vaidyanathan G; Affleck D; Zalutsky MR Nucl Med Biol; 1994 Jan; 21(1):105-10. PubMed ID: 9234271 [TBL] [Abstract][Full Text] [Related]
2. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment. Garg PK; Harrison CL; Zalutsky MR Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501 [TBL] [Abstract][Full Text] [Related]
3. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments. Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab')2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab')2. Wilbur DS; Vessella RL; Stray JE; Goffe DK; Blouke KA; Atcher RW Nucl Med Biol; 1993 Nov; 20(8):917-27. PubMed ID: 8298571 [TBL] [Abstract][Full Text] [Related]
7. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate. Zalutsky MR; Narula AS Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14. Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345 [TBL] [Abstract][Full Text] [Related]
9. Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate. Reist CJ; Foulon CF; Alston K; Bigner DD; Zalutsky MR Nucl Med Biol; 1999 May; 26(4):405-11. PubMed ID: 10382844 [TBL] [Abstract][Full Text] [Related]
10. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies. Garg PK; Garg S; Zalutsky MR Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279 [TBL] [Abstract][Full Text] [Related]
11. Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model. Garg PK; Garg S; Bigner DD; Zalutsky MR Cancer Res; 1992 Sep; 52(18):5054-60. PubMed ID: 1516061 [TBL] [Abstract][Full Text] [Related]
12. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds. Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601 [TBL] [Abstract][Full Text] [Related]
13. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor. Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575 [TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cope DA; Dewhirst MW; Friedman HS; Bigner DD; Zalutsky MR Cancer Res; 1990 Mar; 50(6):1803-9. PubMed ID: 2407344 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies. Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961 [TBL] [Abstract][Full Text] [Related]
16. Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity. Zalutsky MR; Garg PK; Friedman HS; Bigner DD Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7149-53. PubMed ID: 2476813 [TBL] [Abstract][Full Text] [Related]
17. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation. Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142 [TBL] [Abstract][Full Text] [Related]
19. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination. Garg S; Garg PK; Zalutsky MR Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411 [TBL] [Abstract][Full Text] [Related]
20. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods. Garg PK; Alston KL; Zalutsky MR Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]